VALEANT CANADA LP ET AL v. RANBAXY PHARMACEUTICALS CANADA ET AL
Summary of T-2224-16
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: S. 18.1 Patented Medicines (Notice of Compliance) Regulations
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| MINISTER OF HEALTH (THE) | ||
| RANBAXY PHARMACEUTICALS CANADA INC | ||
| VALEANT CANADA LP | Lenczner Slaght Royce Smith | SKODYN, ANDREW |
| VALEANT CNAADA SEC | ||
| VALEANT PHARMACEUTICALS LUXEMBOURG SARL |
| Name | Number |
|---|---|
| 2524300 |
Patented Medicine: Bupropion (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Valeant Canada v Ranbaxy Pharmaceuticals Canada 2018 FC 847 | Aug 20, 2018 | Valeant sought a prohibition order preventing Ranbaxy from marketing Ran-Bupropion XL Tablets, an extended relief medication that Valeant said infringed Patent 2,524,300. The issues as identified by the Court were: a) is the "permeation enhancer" element in a range of about 20% to about 40% of the moisture barrier dry weight essential; b) what is the proper construction of the term "permeation enhancer"; and c) what is the proper construction of the term 'about'. The Court concluded that the essential element of "about 20% to about 40%" meant a deviation of 18% to 44% so the permeation enhancer in the Ranbaxy formulation was outside the scope of "about 20% to about 40%" of the moisture barrier dry weight as claimed. Therefore the Court concluded that Valeant failed to satisfy its onus on a balance of probabilities that Ranbaxy's allegation of non-infringement was unjustified. The Court ordered Ranbaxy's its fees, fixed at a lump sum of $100,000 plus disbursements of no more than $22,000. (Thanks to Kavita Ramamoorthy for a copy of the decision) |
Docket Summary (Google Translate to English)
(32) 2018-10-31 - OttawaCertified French language Translation of Public Judgment and Reasons rendered on 20-AUG-2018 by The Honourable Madam Justice McVeigh filed on 31-OCT-2018 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Judgment entered in J. & O. Book, volume 1389 page(s) 447 - 448 and copy placed on file.
Confirmation of transmittal receipt via facsimile received from all parties with respect to doc. #31 placed on file on 27-SEP-2018
Reasons for Judgment and Judgment (CONFIDENTIAL) dated 20-AUG-2018 rendered by The Honourable Madam Justice McVeigh Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: dismissed Filed on 20-AUG-2018 copies sent to parties Transmittal Letters placed on file. Final Decision Certificate of Judgment entered in J. & O. Book, volume 1385 page(s) 296 - 297
Confirmation of transmittal receipt via facsimile received from all parties with respect to doc. #30 placed on file on 21-AUG-2018
Reasons for Judgment and Judgment (PUBLIC) dated 20-AUG-2018 rendered by The Honourable Madam Justice McVeigh Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: dismissed Filed on 20-AUG-2018 copies sent to parties Transmittal Letters placed on file. Final Decision Certificate of Judgment entered in J. & O. Book, volume 1381 page(s) 320 - 321
Letter from Respondent dated 10-AUG-2018 In response to direction of McVeigh J. dated August 7,2018 re:review of final confidential decision and any proposed redactions of confidential information. Encls. received on 10-AUG-2018
Acknowledgment of Receipt received from 3 counsel for the parties by fax on 07-AUG-2018 with respect to the Oral Direction (ID 48) of McVeigh, J. dated 7-AUG-2018, and a copy of the DRAFT CONFIDENTIAL JUDGMENT AND REASONS (40 pages). placed on file on 07-AUG-2018
Memo to file from Cynthia Leaver, Registry Assistant, Actions Section, Ottawa Registry - On 7-AUG-2018, sent an E-mail to Aalto, P., Case Management Judge, enclosing a copy of the fax letter from Registry to 3 counsel citing Oral Directions of McVeigh, J. dated 7-AUG-2018, and enclosing a scanned copy of the 40-page Confidential Draft Judgment and Reasons. Mr. Prothonotary Aalto acknowledged receipt. placed on file on 07-AUG-2018
Draft JUDGMENT AND REASONS concerning FINAL CONFIDENTIAL DECISION - awaiting parties' reply re: redactions. received on 07-AUG-2018
Oral directions received from the Court: The Honourable Madam Justice McVeigh dated 07-AUG-2018 directing that "Enclosed is a final confidential decision. I asked that counsel please review to ensure that any confidential information is redacted in any public version on this decision and to advise the Court, by August 15, 2018. f you cannot reach an agreement, please advise the Court immediately." Faxed to 3 counsel for the parties on 7-AUG-2018, with DRAFT CONFIDENTIAL JUDGMENT AND REASONS. placed on file on 07-AUG-2018 Confirmed in writing to the party(ies)
Solicitor's certificate of service on behalf of Kavita Ramamoorthy (Respondent - Ranbaxy) confirming service of Doc 28 upon Applicant Respondent - MOH by Personal Serivce (Applicant) & MOH (by email) on 13-JUL-2018 filed on 13-JUL-2018
RANBAXY'S COST SUBMISSIONS on behalf of Respondent filed on 13-JUL-2018
Covering letter from Applicant/Respondent Patentee dated 13-JUL-2018 concerning Doc. Nos. 26 27 placed on file on 13-JUL-2018
Affidavit of service of Doc#26 Cost Submissions sworn on 13-JUL-2018 on behalf of Applicant/Respondent Patentee confirming service of Doc#26 Cost Submission upon Respondent (Ranbaxy Pharmaceuticals Canada Inc.) by personal service on 13-JUL-2018 filed on 13-JUL-2018
Written Submissions on behalf of Applicant and Respondent Patentee concerning Costs with proof of service upon Respondent (The Minister of Health) on 13-JUL-2018 filed on 13-JUL-2018
Letter from Applicant dated 25-JUN-2018 Further to direction of Madam Justice McVeigh re:costs...we write to advise the Court that we have been unable to agree to issue of costs of application Applicant suggests parties be given until July 13,2018 to provide submissions on costs,all due July 13,2018 page limit 1-5 pages. received on 25-JUN-2018
Letter from Applicant dated 18-JUN-2018 Further to direction of McVeigh J. re:costs, hearing June 6,7,2018.The parties request a week until June 25,2018 to advise the Court regarding an agreement. received on 18-JUN-2018
Letter from Respondent dated 27-JUN-2018 We ask that a copy of this letter be placed before Justice McVeigh the hearing Judge who heard application on June 6,7,2018. We write to advise the Court further to correspondence of Valeant dated June 25,2018 that we are in agreement with Valeant's proposal regarding form and timing... received on 27-JUN-2018
Toronto 07-JUN-2018 BEFORE The Honourable Madam Justice McVeigh Language: E Before the Court: Judicial Review Result of Hearing: Matter reserved held in Court in camera Senior Usher: JOHN GRISE Duration per day: 06-JUN-2018 from 09:31 to 16:18 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Michelle Gauvin 07-JUN-2018 from 09:29 to 13:04 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Michelle Gauvin Total Duration: 10h 23min Appearances: ANDREW SKODYN 416-865-2882 representing Applicant and Respondent/Patentee MELANIE K.BAIRD 416-865-2948 representing Applicant and Respondent/Patentee KAVITA RAMAMOORTHY & KERRY ANDRUSIAK 647-795-8635 representing RESPONDENT, RANBAXY PHARMA Comments: PARTIES TO PROVIDE JOINT LETTER ON COSTS BY 18-JUN-2018 DARS Z009113 USED TO RECORD CONFIDENTIAL HEARING Minutes of Hearing entered in Vol. 999 page(s) 452 - 464 Abstract of Hearing placed on file
CERTIFIED COPY OF DOCUMENTS ON FILE IN THE PATENT OFFICE-admitted in evidenc per section 14 of Patent Act received at hearing on 06-JUN-2018
CONFIDENTIAL RESPONDENT'S COMPENDIUM FOR JUDGE received at hearing on 06-JUN-2018
CONFIDENTIAL APPLICANT'S COMPENDIUM FOR JUDGE received at hearing on 06-JUN-2018
SUPPLEMENTARY BOOK OF AUTHORITIES consisting of 1 volume(s) on behalf of Applicant and Respondent/Patentee received on 06-JUN-2018 Sent directly to Presiding Judge
Letter from Respondent dated 01-MAY-2018 advising of the name change of the name change of the Respondent's firm, from Fineberg Legal LLP to Fineberg Ramamoorthy LLP (cc'd to all parties) received on 01-MAY-2018
Application Record: Memorandum of Fact & Law (Public version of doc 23) on behalf of Respondent (Ranbaxy) filed on 30-APR-2018
Solicitor's certificate of service on behalf of Kavita Ramamoorthy confirming service of doc 23 & authorities upon Applicant & Minister by hand delvery on 30-APR-2018 filed on 30-APR-2018
Book of Authorities consisting of 2 volume(s) on behalf of Respondent (Ranbaxy) received on 30-APR-2018
Sealed envelope pursuant to Order dated 24-OCT-2017 on behalf of Respondent purporting to contain Respondent's Application Record (Memo of Fact & Law) Filed on 30-APR-2018
Brief of Authorities consisting of 1 volume(s) on behalf of Applicant and Respondent/Patentee received on 28-FEB-2018 Sent directly to Presiding Judge
Affidavit of service of Heather Johnson sworn on 28-FEB-2018 on behalf of Applicant Respondent/Patentee confirming service of Doc. # 20 upon Respondent - Minister of Health by personal service on 28-FEB-2018 filed on 28-FEB-2018
Affidavit of service of Heather Johnson sworn on 28-FEB-2018 on behalf of Applicant/ Respondent/Patentee confirming service of Doc. # 20 upon Respondent - Ranbaxy by personal service on 28-FEB-2018 filed on 28-FEB-2018
Application Record - 4 Volumes Number of copies received/prepared: 3 on behalf of Applicant and Respondent/Patentee - vol. 1 to 4-Partially Confidential filed on 28-FEB-2018
Confirmation of Transmittal receipt via facsimile received from all parties with respect to doc. #19 placed on file on 10-NOV-2017
Order (time and place) dated 10-NOV-2017 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Judicial Review (s.18) Trade-Marks - Application to be heard at Special Sitting in Toronto on 06-JUN-2018 to begin at 09:30 duration: 1d 4h language: E Filed on 10-NOV-2017 cc's sent to parties entered in J. & O. Book, volume 1350 page(s) 311 - 312 Transmittal letters placed on file
Communication to the Court from the Registry dated 02-NOV-2017 re: Requisition for hearing
Solicitor's certificate of service on behalf of Andrew Skodyn confirming service of doc 17 upon all parties by telecopier on 27-OCT-2017 filed on 27-OCT-2017
Requisition for hearing - Application from Applicant filed on 27-OCT-2017 Tariff Application or appeal - $50.00
Solicitor's certificate of service on behalf of Melanie Baird confirming service of Expert Reports of Dr. Loyd V. Allen and Robert Joseph Timko upon all parties by courier on 25-OCT-2017 filed on 27-OCT-2017
Solicitor's certificate of service on behalf of Kavita Ramamoorthy confirming service of Ranaxy Pharmaceuticals Canada's responding evidence upon the Applicant and Respondent/Patentee by personal service on 16-OCT-2017 confirming service Ranaxy Pharmaceuticals Canada's responding evidence upon Respondent (Minister of Health) by personal service on 16-OCT-2017 filed on 25-OCT-2017
Acknowledgment of Receipt received from the parties (via email) with respect to order doc. 13 and direction doc. 14 placed on file on 24-OCT-2017
Written directions received from the Court: Kevin Aalto, Prothonotary dated 24-OCT-2017 directing that the following timetable shall govern this application: 1) parties to file proof of service of their respective evidence by 27-OCT-2017; 2) requisition for hearing to be filed by 30-OCT-2017; 3) cross-exams to be completed by 13-DEC-2017; 4) applicant's record to be served and filed by 28-FEB-2018; 5) respondent's record to be served and filed by 30-APR-2018 filed on 24-OCT-2017
Confidentiality order dated 24-OCT-2017 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent dated 23-OCT-2017 Result: granted Filed on 24-OCT-2017 copies sent to parties entered in J. & O. Book, volume 1348 page(s) 347 - 350 Interlocutory Decision
Solicitor's certificate of service on behalf of Kavita Ramamoorthy confirming service of Doc#11 Notice of Change of Solicitor upon all parties by telecopier on 24-AUG-2017 filed on 24-AUG-2017
Notice of change of solicitor on behalf of Respondent, RANBAXY PHARMACEUTICALS CANADA INC. filed on 24-AUG-2017
Acknowledgment of Receipt received from the parties (via email) with respect to order docs. 9 and 10 placed on file on 21-FEB-2017
Protective order dated 21-FEB-2017 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from the parties dated 17-FEB-2017 Result: granted Filed on 21-FEB-2017 copies sent to parties entered in J. & O. Book, volume 1327 page(s) 61 - 72 Interlocutory Decision
Production order dated 21-FEB-2017 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from the parties dated 17-FEB-2017 Result: granted Filed on 21-FEB-2017 copies sent to parties entered in J. & O. Book, volume 1327 page(s) 43 - 46 Interlocutory Decision
Acknowledgment of Receipt received from all parties (by fax) with respect to doc 8 placed on file on 05-JAN-2017
Order dated 04-JAN-2017 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: IT IS ORDERED pursuant to Rule 383 that Prothonotary Kevin R. Aalto is assigned as Case management Judge in this matter. Filed on 04-JAN-2017 copies sent to parties entered in J. & O. Book, volume 1323 page(s) 198 - 198 Interlocutory Decision
Solicitor's certificate of service on behalf of Kavita Ramamoorthy confirming service of Doc. 6 upon Applicant by telecopier on 29-DEC-2016 confirming service Doc. 6 upon Respondent/Patentee, Valeant Pharmaceuticals Luxemborg S.A.R.L. by telecopier on 29-DEC-2016 confirming service dOC. 6 upon Respondent, The Minister of Health by telecopier on 29-DEC-2016 filed on 29-DEC-2016
Notice of appearance on behalf of Respondent, Ranbaxy Pharmaceuticals Canada Inc. filed on 29-DEC-2016
Service copy of Doc. No. 1 with proof of service upon Deputy Attorney General of Canada (Minister of Health) on 22-DEC-2016 filed on 22-DEC-2016
Covering letter from Respondent Ministry of Health dated 23-DEC-2016 concerning Doc. Nos. 3 4 placed on file on 23-DEC-2016
Affidavit of service of James Adeney sworn on 23-DEC-2016 on behalf of Respondent Ministry of Health confirming service of Doc. 3 upon all parties by telecopier on 23-DEC-2016 with Exhibits A filed on 23-DEC-2016
Notice of appearance on behalf of Respondent Ministry of Health filed on 23-DEC-2016
Affidavit of service of Chris Campbell sworn on 22-DEC-2016 on behalf of Applicant confirming service of DOC.1 upon Respondent by personal service on 22-DEC-2016 filed on 23-DEC-2016
Notice of application and 2 copies with regard to Patented Medicines (NOC) letter 8-Nov-2016; S.4 PM(NOC) Regulations. filed on 22-DEC-2016 Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes
The official version of the court proceeding information is available from the court websites directly: